GeneChem

Venture capital firm from Quebec, Canada investing in companies that are involved in drug discovery and development

GeneChem is a venture capital firm that centers on biotechnology venture capital funds. They have over $350M in assets circulated in four funds: GeneChem Technologies, GeneChem Therapeutics, Agechem and AmorChem. Since 1997, GeneChem has been active in putting resources into companies that are focused on drug discovery and development. They have put resources into more than 60 companies situated in the US, Canada and Europe.

GeneChem is headquartered in Montreal, Quebec. It has an income of $2.5M, and has 10 employees. It has obtained around $44.2M in funds. It has 9 companies in its portfolio. It takes part in everything from seed and startup financings to later stage mezzanine rounds to PIPE (private placements in public equities) funds. GeneChem usually puts resources into genomics with focus on gene discovery, functional genomics, bioinformatics, proteomics, and gene therapy among others.

Timeline

1997

Founded

People

Name
Role
LinkedIn

Fabienne Perreau

Administrative Assistant

Inès Holzbaur

General Partner

Maxime Pesant

Vice-President, Finance

Patricia Laplante

Project Manager

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Ambit Biosciences

NuChem Therapeutics

Osprey Pharmaceuticals USA

Sonexa Therapeutics

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.